logologo
QuantliQuantli

Climb Bio Inc

CLYM

NASDAQ

Biotechnology

$16.33

USD

+1.60 (+10.86%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $846.04M

Volume 2.5M

Price Target

$17.00$35.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $35.00 and a min estimate of $17.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$23.00

+$3.6 vs prior

Implied Upside

+40.9%

+22.1% vs prior

Analyst Covering

4

-6 vs prior period

Consensus

Buy

Declined vs prior

Signal Quality

Consensus Freshness

29%

Many ratings are older - consensus may be less current

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$3.00 Gap

Median $20.00 vs avg $23.00 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Raghuram Selvaraju

HC Wainwright & Co.

Buy

Reiterated

1 month ago

Plus
Plus
Plus

Laura Chico

Wedbush

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Julian Harrison

BTIG

Buy

Maintained

2 months ago

Plus
Plus
Plus

Yatin Suneja

Guggenheim

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

GERN

Geron Corp

$1.47

-4.2%

DSGN

Design Therapeutics Inc

$14.83

+3.1%

ODTX

Odyssey Therapeutics Inc

$20.73

+0.1%

JANX

Janux Therapeutics Inc

$16.12

+0.8%

ANNX

Annexon Inc

$5.29

+0.6%

CADL

Candel Therapeutics Inc

$11.72

-0.7%

OLMA

Olema Pharmaceuticals Inc

$10.63

+1.1%

KURA

Kura Oncology Inc

$10.86

+7.6%

FTH

Faeth Therapeutics, Inc

$32.34

+13.3%